Follow

@thejapantimes But they're not undercutting the FDA. They're grappling with the FDA running afoul of its own standards.

The courts in this case are trying to figure out how to deal with an FDA that undercut itself, looking at the FDA's own records of dubious approval to sort out what to do now.

Sign in to participate in the conversation
CleverLibre Social

CleverLibre Social is an inclusive social instance for open discussion, learning, and community.
All cultures welcome.
Hate speech and harassment strictly forbidden.